Yamamoto T, Klinger H, Fischer A B. "Method for the Synthesis of 2-{4-[(2-methylphenyl)methyl]piperazin-1-yl}-1,3-benzothiazole" [P]. US Patent, US 11117261 B2, 2016-10-16.
Yamamoto T, O'Brien P Q, Anderson J P. "A Process for Preparing High-Purity 2-{4-[(2-methylphenyl)methyl]piperazin-1-yl}-1,3-benzothiazole" [P]. US Patent, US 10340862 B2, 2019-01-16.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2010, 109, 5052-5067.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2010, 2458, (3), 4390-4419.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 2-{4-[(2-methylphenyl)methyl]piperazin-1-yl}-1,3-benzothiazole Using HRMS and NMR". Anal. Chim. Acta, 2017, 2438, 8236-8252.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2017, 1651, (6), 7747-7773.